Results 251 to 260 of about 1,212,027 (321)
Some of the next articles are maybe not open access.
Localized and systemic scleroderma
Seminars in Cutaneous Medicine and Surgery, 2001Scleroderma is a broad term encompassing both localized and systemic sclerosis. Localized scleroderma is a cutaneous limited fibrosis that manifests as plaque morphea, generalized morphea, linear scleroderma, and deep morphea. Systemic scleroderma (sclerosis) can manifest as either limited or diffuse disease.
J C English rd, A Hawk
openaire +3 more sources
HLA in Systemic Scleroderma (PSS) and Familial Scleroderma
The Journal of Dermatology, 1991AbstractHLA in systemic scleroderma (PSS), including three familial cases, is reported. Three families in which one sister developed PSS and another sister suffered from either PSS (family 1), mixed connective tissue disease (MCTD) (family 2), or Sjögren's syndrome (SjS) (family 3) were described.
Hideki Ono+3 more
openaire +3 more sources
Medical ultrasonography, 2014
AIMS Pulmonary fibrosis is the main cause of mortality in patients with Systemic Scleroderma (SSc). This study was performed to investigate the utility of modified trans-thoracic ultrasound (TTUS) scoring system according to the comet tail sign (B-line ...
A. Mohammadi+2 more
semanticscholar +1 more source
AIMS Pulmonary fibrosis is the main cause of mortality in patients with Systemic Scleroderma (SSc). This study was performed to investigate the utility of modified trans-thoracic ultrasound (TTUS) scoring system according to the comet tail sign (B-line ...
A. Mohammadi+2 more
semanticscholar +1 more source
Medical Clinics of North America, 1989
Scleroderma encompasses a wide variety of diseases, including localized scleroderma, overlap syndromes, sclerodermoid conditions, and systemic scleroderma. This article emphasizes the systemic scleroderma.
openaire +2 more sources
Scleroderma encompasses a wide variety of diseases, including localized scleroderma, overlap syndromes, sclerodermoid conditions, and systemic scleroderma. This article emphasizes the systemic scleroderma.
openaire +2 more sources
Systemic sclerosis or scleroderma
Independent Nurse, 2007This article provides a definition of systemic sclerosis orscleroderma and its epidemiology
Josip Car, Aziz Sheikh
openaire +2 more sources
Current Rheumatology Reports, 2001
Systemic scleroderma in children is very rare and is considered similar to adult-onset disease. In adults, new etiopathogenetic and therapeutic approaches have emerged in recent years. For instance, it has been shown that microchimerism could play a role in disease pathogenesis and that immunoablation followed by stem cell rescue could be of potential ...
openaire +3 more sources
Systemic scleroderma in children is very rare and is considered similar to adult-onset disease. In adults, new etiopathogenetic and therapeutic approaches have emerged in recent years. For instance, it has been shown that microchimerism could play a role in disease pathogenesis and that immunoablation followed by stem cell rescue could be of potential ...
openaire +3 more sources
Journal of the American Academy of Dermatology, 1988
Systemic scleroderma is a generalized disease of connective tissue involving mainly the skin, the gastrointestinal tract, the lungs, the heart, and the kidneys. It can be present in different forms, of which acroscleroderma, with limited cutaneous and extracutaneous involvement, and diffuse scleroderma within a more rapid progression are most ...
Michael Meurer, Thomas Krieg
openaire +3 more sources
Systemic scleroderma is a generalized disease of connective tissue involving mainly the skin, the gastrointestinal tract, the lungs, the heart, and the kidneys. It can be present in different forms, of which acroscleroderma, with limited cutaneous and extracutaneous involvement, and diffuse scleroderma within a more rapid progression are most ...
Michael Meurer, Thomas Krieg
openaire +3 more sources
Systemic scleroderma: a spatiotemporal clustering
Internal Medicine Journal, 2005AbstractBackground and aims: The aetiology of systemic scleroderma remains poorly understood. Twin studies suggest a low genetic input. Of the incriminated environmental agents, silica and vinyl chloride monomer exposure appear the most convincing. Spatiotemporal clustering has been demonstrated only three times previously.
Englert, H+7 more
openaire +4 more sources
Progressive Systemic Sclerosis (Scleroderma)
New England Journal of Medicine, 1953THE skin manifestations of scleroderma have long been recognized and adequately described. These features are usually identified readily, particularly in the later phases of the disease when the spectacular, hardened, bound-down, wrinkleless appearance of the skin is so characteristic as to supply a descriptive name for the illness. This term refers to
Theodore B. Bayles+2 more
openaire +4 more sources
Scleroderma-Inducing Glycosaminoglycan in the Urine of Patients with Systemic Scleroderma
Dermatology, 1978A glycosaminoglycan with scleroderma-inducing effect was isolated and partially purified from the urine of patients with systemic scleroderma. The glycosaminoglycan was an N-sulfated glycosaminoglycuronan and its high total sulfate and 2,5-anhydromannose contents suggest that the glycosaminoglycan is a degradation product of heparin or polysulfated ...
Hidekazu Ishikawa+3 more
openaire +3 more sources